| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 192-198, Copyright © 1989 by Endocrine Society
ARTICLES |
ZS Krozowski, SE Rundle, C Wallace, MJ Castell, JH Shen, J Dowling, JW Funder and AI Smith
Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia.
We have synthesized three peptides corresponding to putative antigenic regions in the immunogenic domain, hinge region, and carboxy-terminus of the protein. A rabbit immunized with a peptide derived from the hinge region of the receptor produced an antiserum which showed 50% displacement with 20 pg peptide at a final serum dilution of 1:35,000. When the antiserum was immunopurified and applied to sections of intact rat and human kidney it stained cells lining segments corresponding to distal tubule, connecting piece, and initial cortical collecting duct, consistent with the known sites of mineralocorticoid action. In both human (formaldehyde-fixed) and rat (Bouin's solution) there was ample evidence for both nuclear and cytoplasmic staining. The thymus, in which previously we have found [3H]aldosterone binding to be below detection limits, showed little or no staining. Western blot analyses demonstrated that the polyclonal antibody recognized an epitope of the expected molecular size. The availability of antibodies to the mineralocorticoid receptor should, thus, facilitate investigation of the steroid specificity-conferring mechanism which allows mineralocorticoids, but not glucocorticoids, access to the nonselective receptor in the kidney.
This article has been cited by other articles:
![]() |
C. E. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, J. Estess, M. P. Warden, M. T. Gomez-Sanchez, and E. P. Gomez-Sanchez Development of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor Endocrinology, March 1, 2006; 147(3): 1343 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Mittelstadt and J. D. Ashwell Disruption of Glucocorticoid Receptor Exon 2 Yields a Ligand-Responsive C-Terminal Fragment that Regulates Gene Expression Mol. Endocrinol., August 1, 2003; 17(8): 1534 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Menuet, S. Viengchareun, P. Penfornis, F. Walker, M.-C. Zennaro, and M. Lombes Targeted Oncogenesis Reveals a Distinct Tissue-specific Utilization of Alternative Promoters of the Human Mineralocorticoid Receptor Gene in Transgenic Mice J. Biol. Chem., March 10, 2000; 275(11): 7878 - 7886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Reilly and D. H. Ellison Mammalian Distal Tubule: Physiology, Pathophysiology, and Molecular Anatomy Physiol Rev, January 1, 2000; 80(1): 277 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kato, H. Sasano, S. Ohara, H. Sekine, S. Mochizuki, T. Mune, K. Yasuda, H. Nagura, T. Shimosegawa, T. Toyota, et al. Coexpression of Mineralocorticoid Receptors and 11{beta}-Hydroxysteroid Dehydrogenase 2 in Human Gastric Mucosa J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2568 - 2573. [Abstract] [Full Text] |
||||
![]() |
G. Hirasawa, H. Sasano, T. Suzuki, J. Takeyama, Y. Muramatu, K. Fukushima, N. Hiwatashi, T. Toyota, H. Nagura, and Z. S. Krozowski 11{beta}-Hydroxysteroid Dehydrogenase Type 2 and Mineralocorticoid Receptor in Human Fetal Development J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1453 - 1458. [Abstract] [Full Text] |
||||
![]() |
G.-H. Kim, S. Masilamani, R. Turner, C. Mitchell, J. B. Wade, and M. A. Knepper The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein PNAS, November 24, 1998; 95(24): 14552 - 14557. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, H. Sasano, S. Suzuki, G. Hirasawa, J. Takeyama, Y. Muramatsu, F. Date, H. Nagura, and Z. S. Krozowski 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Lung: Possible Regulator of Mineralocorticoid Action J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4022 - 4025. [Abstract] [Full Text] |
||||
![]() |
L.-J. Dai, G. Ritchie, B. Bapty, and G. A. Quamme Aldosterone potentiates hormone-stimulated Mg2+ uptake in distal convoluted tubule cells Am J Physiol Renal Physiol, February 1, 1998; 274(2): F336 - F341. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hirasawa, H. Sasano, K.-i. Takahashi, K. Fukushima, T. Suzuki, N. Hiwatashi, T. Toyota, Z. S. Krozowski, and H. Nagura Colocalization of 11{beta}-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Epithelia J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3859 - 3863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Odermatt, P. Arnold, and F. J. Frey The Intracellular Localization of the Mineralocorticoid Receptor Is Regulated by 11beta -Hydroxysteroid Dehydrogenase Type 2 J. Biol. Chem., July 20, 2001; 276(30): 28484 - 28492. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |